KIT and central nervous system germinoma: The KIT mutation and mTOR mutation were confirmed in CNS germinomas and could be the potential target for therapy.316,323 However, no related KIT or mTOR pathway-targeted clinical trials have been recruited or carried out for CNS germinomas.